Integra LifeSciences Holdings Corporation
Price Action
Technical Summary
EMERGING TRENDIntegra LifeSciences Holdings Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 92), indicating clear outperformance against the broad market. Earnings growth of 82% provides fundamental context to the price action. Investors should exercise caution due to high volatility (61% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $17.77 | -1.74% | BELOW |
| 50 SMA | $15.49 | +12.72% | ABOVE |
| 100 SMA | $12.86 | +35.78% | ABOVE |
| 150 SMA | $12.72 | +37.21% | ABOVE |
| 200 SMA | $12.93 | +35.07% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IART in an uptrend right now?
IART has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is IART overbought or oversold?
IART's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is IART outperforming the market?
IART has a Relative Strength (RS) Rating of 92 out of 99. Yes, IART is a market leader, outperforming 92% of all stocks over the past 12 months.
Where is IART in its 52-week range?
IART is trading at $17.46, which is 92% of its 52-week high ($18.92) and 86% above its 52-week low ($8.70).
How volatile is IART?
IART has a Beta of 1.99 and 52-week volatility of 61%. It's more volatile than the S&P 500 - expect bigger swings.